Provided herein are compounds, pharmaceutical compositions and combination therapies for treatment of hepatitis C.
本文提供了治疗丙型肝炎的化合物、药物组合和联合疗法。
TRICYCLIC FUSED RING INHIBITORS OF HEPATITIS C
申请人:Li Leping
公开号:US20130296304A1
公开(公告)日:2013-11-07
Provided herein are compounds, pharmaceutical compositions and combination therapies for treatment of hepatitis C.
本文提供了用于治疗丙型肝炎的化合物、药物组合和联合治疗方案。
Electrochemistry of triazenes — 2. Formation of the 2,7-dimethoxy-5,10-dimethyl-5,10-dihydrophenazine radical cation during oxidation of 1,3-diaryl-3-methyltriazenes
作者:Bernd Speiser、Hartmut Stahl
DOI:10.1016/s0040-4039(00)60101-6
日期:1992.7
Anodic oxidation of various 1,3-diaryl-3-methyltriazenes proceeds via the radicalcation. During the oxidation of 1-aryl-3-methyl-3-(p-methoxyphenyl)triazenes a common product is found and identified by means of ESR- and ENDOR-spectroscopy: the 2,7-dimethoxy-5,10-dimethyl-5,10-dihydrophenazine radicalcation. The occurence of this species confirms the postulated cleavage between nitrogen atoms N(2)